SCHEMBL13720178

SCHEMBL13720178

N#CC(CC(O)COCc1ccccc1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.54
CA2 P00918 1/20 0.54
CA7 P43166 1/20 0.54
CA9 Q16790 1/20 0.54
TACR1 P25103 3/20 0.45
MAPK1 P28482 1/20 0.45
TSHR P16473 2/20 0.43
CTSL P07711 1/20 0.42
CTSS P25774 1/20 0.42
CTSK P43235 1/20 0.42
KMT2A Q03164 1/20 0.42
POLB P06746 1/20 0.41
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
AGER Q15109 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4022770 1.00 CA1 (0.54) CA1CA2CA7CA9TACR1
SCHEMBL13720747 0.86 CA1 (0.41) CA1CA2CA7CA9TACR1
SCHEMBL397022 0.77 CA1 (0.78) CA1CA2CA7CA9TACR1
SCHEMBL8328277 0.76 CA1 (0.62) CA1CA2CA7CA9TACR1
SCHEMBL27686748 0.76 CA1 (0.62) CA1CA2CA7CA9TACR1
SCHEMBL6580596 0.76 CA1 (0.62) CA1CA2CA7CA9TACR1
SCHEMBL2628026 0.75 TSHR (0.45) TACR1TSHRCTSLCTSSCTSK
SCHEMBL7153591 0.73 CA1 (0.76) CA1CA2CA7CA9TACR1
SCHEMBL1344877 0.73 TSHR (0.50) TSHRKMT2APOLBCYP1A2CYP3A4
SCHEMBL23258692 0.72 CA1 (0.70) CA1CA2CA7CA9TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7569579-B2 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome SMITHKLINE BEECHAM CORPORATION (US) 2009-08-04 US disclosed